Scaffolds, Stem Cells, and Tissues. Oh, My!
A primer for how the FDA regulates stem cells
A primer for how the FDA regulates stem cells
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
The Women and Equalities Committee's report highlights patient safety failures tied to unregulated surgical and non-surgical cosmetic procedures, including gaps in data collection, informed consent, and clinical oversight.